Human Chorionic Gonadotropin Biology and Clinical Applications
Summary
Human chorionic gonadotropin (hCG) is a central glycoprotein hormone secreted by placental trophoblasts that sustains early pregnancy through luteal support and modulates maternal physiology by promoting angiogenesis, immune tolerance and uterine quiescence. Comprising an alpha and a unique beta subunit, hCG binds to the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) on target cells to activate downstream signalling cascades. Beyond the classical heterodimer, several variants exist, notably hyperglycosylated hCG produced by invasive cytotrophoblasts to facilitate implantation and placental vascular remodelling. Free beta-subunit forms arising from non-trophoblastic malignancies act as autocrine factors promoting tumour growth. Clinically, measurement of total hCG and its variants underpins pregnancy detection, monitoring of trophoblastic disease, prenatal screening for chromosomal abnormalities and assessment of placental insufficiency. In oncology, aberrant hCG expression or ectopic β-subunit correlates with disease severity in cancers such as breast and ovarian carcinoma, offering both prognostic information and potential therapeutic targets. Advances in glycomics and molecular pathology continue to refine understanding of hCG heterogeneity and to expand its utility in maternal–fetal medicine and cancer management worldwide.
Research from Nature Portfolio
Recent studies have evaluated serum β-hCG levels as a prognostic indicator in women with palpable breast malignancies. Analysis of two hundred patients found that while absolute β-hCG values remained below conventional diagnostic thresholds, a lower cut-off of approximately 2 mIU/mL distinguished individuals with more advanced tumour stage and higher proliferative indices. Those with elevated β-hCG within this subthreshold range exhibited significantly poorer clinical outcomes, suggesting that serum β-hCG may serve as an adjunct marker for stratifying breast cancer severity and guiding therapeutic decisions.
Human Chorionic Gonadotropin Biology and Clinical Applications publication trend
The graph below shows the total number of articles in human chorionic gonadotropin biology and clinical applications across all publications each year (not limited to Nature Index journals).
Technical terms
Human chorionic gonadotropin (hCG): glycoprotein hormone composed of α- and β-subunits, secreted by placental trophoblasts to support corpus luteum function and modulate maternal physiology.
Hyperglycosylated hCG (H-hCG): variant of hCG with extended carbohydrate moieties produced by invasive cytotrophoblasts, essential for trophoblast invasion and placental vascular development.
Luteinizing hormone/chorionic gonadotropin receptor (LHCGR): G-protein-coupled receptor that mediates signalling of luteinizing hormone and hCG in ovarian, uterine and other tissues.
Trophoblast: specialised placental cell lineage—including cytotrophoblasts and syncytiotrophoblasts—responsible for implantation, placental formation and maternal–fetal exchange.
References
- Hyperglycosylated-hCG: Its Role in Trophoblast Invasion and Intrauterine Growth Restriction. Cells (2023).
- Biochemical Screening for Fetal Trisomy 21: Pathophysiology of Maternal Serum Markers and Involvement of the Placenta. International Journal of Molecular Sciences (2023).
- Association of serum beta hCG levels in women with palpable malignant breast lesions. Scientific Reports (2023).
- hCG: Biological Functions and Clinical Applications. International Journal of Molecular Sciences (2017).
- Human Chorionic Gonadotropin and Breast Cancer. International Journal of Molecular Sciences (2017).
- Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer. BMC Cancer (2012).
- Insights into the hyperglycosylation of human chorionic gonadotropin revealed by glycomics analysis. PLOS ONE (2020).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.